Rocket Pharmaceuticals’ (RCKT) Hold Rating Reiterated at TD Cowen
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report)‘s stock had its “hold” rating restated by equities researchers at TD Cowen in a report issued on Tuesday, Marketbeat.com reports. Other research analysts also recently issued reports about the company. BMO Capital Markets assumed coverage on Rocket Pharmaceuticals in a research note on Wednesday, March 12th. They issued […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report)‘s stock had its “hold” rating restated by equities researchers at TD Cowen in a report issued on Tuesday, Marketbeat.com reports. Other research analysts also recently issued reports about the company. BMO Capital Markets assumed coverage on Rocket Pharmaceuticals in a research note on Wednesday, March 12th. They issued […]
